Results for tag: "Resorbable Vascular Scaffold"

The Resorbable Vascular Scaffold (RVS) market is a segment of the Cardiovascular Devices industry. RVS are medical devices used to treat coronary artery disease, a condition caused by the narrowing of the arteries that supply blood to the heart. RVS are designed to be implanted in the artery and gradually dissolve over time, allowing the artery to return to its natural state. This technology has been shown to reduce the risk of restenosis, a condition in which the artery becomes narrowed again after treatment. RVS are becoming increasingly popular due to their ability to reduce the risk of restenosis and the fact that they do not require a second procedure to remove the device. Additionally, RVS are less invasive than traditional stents, which require a larger incision and a longer recovery time. Some companies in the RVS market include Abbott, Biotronik, Boston Scientific, Medtronic, and Terumo. Show Less Read more